Inventor · disambiguated record
Argyrios G. Arvanitis
Also filed as: ARVANITIS ARGYRIOS · ARVANITIS ARGYRIOS G · ARVANITIS ARGYRIOS GEORGIOUS
22 granted patents·6 pending applications·1,093 citations·filing 1998–2019
97Inventor score
Files withINCYTE CORP9RODGERS JAMES D6ARVANITIS ARGYRIOS G3BRISTOL MYERS SQUIBB CO3BRISTOL MYERS SQUIBB PHARMA CO3
Top patents by PatentIndex Score
28 records- 0198US9359358B2Cyclohexyl azetidine derivatives as JAK inhibitorsRODGERS JAMES D·Filed 2012·Granted Jun 7, 2016·81 cites·30 claims
- 0298US8835423B2Azepine inhibitors of janus kinasesINCYTE CORP·Filed 2013·Granted Sep 16, 2014·71 cites·33 claims
- 0398US8716303B2N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitorsRODGERS JAMES D·Filed 2010·Granted May 6, 2014·109 cites·74 claims
- 0498US8415362B2Pyrazolyl substituted pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitorsRODGERS JAMES D·Filed 2008·Granted Apr 9, 2013·117 cites·21 claims
- 0597US9334274B2N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitorsINCYTE CORP·Filed 2014·Granted May 10, 2016·57 cites·34 claims
- 0697US8889697B2Metabolites of the janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrileRODGERS JAMES D·Filed 2010·Granted Nov 18, 2014·79 cites·6 claims
- 0797US8841318B2Substituted heterocycles as janus kinase inhibitorsINCYTE CORP·Filed 2013·Granted Sep 23, 2014·72 cites·14 claims
- 0896US8748401B2Hydroxyl, keto, and glucuronide derivatives of 3-(4-(7H pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrileRODGERS JAMES D·Filed 2013·Granted Jun 10, 2014·80 cites·11 claims
- 0996US8563541B2Azepine inhibitors of Janus kinasesARVANITIS ARGYRIOS G·Filed 2012·Granted Oct 22, 2013·92 cites·44 claims
- 1096US8513270B2Substituted heterocycles as Janus kinase inhibitorsARVANITIS ARGYRIOS G·Filed 2007·Granted Aug 20, 2013·87 cites·35 claims
- 1196US8486902B2Hydroxyl, keto, and glucuronide derivatives of 3-(4-(7H-pyrrolo[2,3-d] pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrileRODGERS JAMES D·Filed 2010·Granted Jul 16, 2013·125 cites·14 claims
- 1292US10463667B2Metabolites of the janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrileINCYTE CORP·Filed 2017·Granted Nov 5, 2019·5 cites·26 claims
- 1387US9512161B2Hydroxyl, keto, and glucuronide derivatives of 3-(4-(7H-pyrrolo[2,3-D]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrileINCYTE CORP·Filed 2014·Granted Dec 6, 2016·9 cites·6 claims
- 1486US6642230B2Imidazopyrimidines and imidazopyridines for the treatment of neurological disordersBRISTOL MYERS SQUIBB PHARMA CO·Filed 2001·Granted Nov 4, 2003·22 cites·5 claims
- 1586US6525056B2Heterocyclyl-substituted ring-fused pyridines and pyrimidines as corticotropin releasing hormone (CRH) antagonists, useful for treating cns and stress-related disordersBRISTOL MYERS SQUIBB CO·Filed 2001·Granted Feb 25, 2003·22 cites·16 claims
- 1681US6143743AImidazopyrimidines and imidazopyridines for the treatment of neurological disordersDU PONT PHARM CO·Filed 1998·Granted Nov 7, 2000·41 cites·8 claims
- 1775US2020038404A1METABOLITES OF THE JANUS KINASE INHIBITOR (R)-3-(4-(7H-PYRROLO[2,3-d]PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL)-3-CYCLOPENTYLPROPANENITRILEINCYTE CORP·Filed 2019·Application pending·0 cites
- 1872US2015164900A1METABOLITES OF THE JANUS KINASE INHIBITOR (R)-3-(4-(7H-PYRROLO[2,3-d]PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL)-3-CYCLOPENTYLPROPANENITRILEINCYTE CORP·Filed 2014·Application pending·0 cites
- 1969US7045529B2Imidazopyrimidinyl and imidazopyri dinyl derivativesBRISTOL MYERS SQUIBB PHARMA CO·Filed 2000·Granted May 16, 2006·4 cites·21 claims
- 2066US7112585B2Pyrimidine derivatives as corticotropin releasing factor inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Sep 26, 2006·3 cites·16 claims
- 2166US7030145B2Pyridinyl derivatives for the treatment of depressionBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Apr 18, 2006·3 cites·11 claims
- 2266US2009197869A1Azepine inhibitors of janus kinasesINCYTE CORP A DELAWARE CORP·Filed 2009·Application pending·0 cites
- 2361US6362180B1Imidazopyridines for the treatment of neurological disordersBRISTOL MYERS SQUIBB PHARMA CO·Filed 1998·Granted Mar 26, 2002·14 cites·2 claims
- 2461US2009215766A1Tetracyclic inhibitors of janus kinasesINCYTE CORP·Filed 2008·Application pending·0 cites
- 2558US2007149506A1Azepine inhibitors of Janus kinasesARVANITIS ARGYRIOS G·Filed 2006·Application pending·0 cites
- 2644US2013137681A1HETEROARYL SUBSTITUTED PYRROLO[2,3-b]PYRIDINES AND PYRROLO[2,3-b]PYRIMIDINES AS JANUS KINASE INHIBITORSINCYTE CORP·Filed 2013·Application pending·0 cites
- 2742US6969721B2Tricyclic-2-pyridone compounds useful as HIV reverse transcriptase inhibitorsBRISTOL MYERS SQUIBB PHARMA·Filed 2003·Granted Nov 29, 2005·0 cites·12 claims
- 2831US6596729B2Tricyclic-2-pyridone compounds useful as HIV reverse transcriptase inhibitorsSQUIBB BRISTOL MYERS PHARMA CO·Filed 2001·Granted Jul 22, 2003·0 cites·22 claims
Join the waitlist — get patent alerts
Get an alert when Argyrios G. Arvanitis files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →